JUN 05, 2019 11:43 AM PDT

Novel Strategy for Drug Discovery and Development

WRITTEN BY: Nouran Amin

Researchers at Dartmouth College have developed a novel strategy for drug discovery and development such development can be used to target new therapies against cancer and possibly neurodegenerative diseases.

Learn more about the traditional process involved in drug discovery and development:

The new technique utilizes a novel synthesis approach by uniting molecular building blocks for a class of organic compounds known as tetracyclic terpenoids—which are responsible for the generation of many FDA-approved drugs and are considered the most successful class of natural product-inspired pharmaceuticals.

"Until now, there was nothing like this available for drug discovery and development," said Glenn Micalizio, the New Hampshire Professor of Chemistry at Dartmouth. "While additional development is expected to enhance the power of this new technology, I believe that we are at the beginning of establishing a truly enabling and potentially transformative technology for the pharmaceutical industry."

Ultimately, the process combines two new chemical reactions that establish bonds between carbon atoms with a unique metal-centered ring-forming reaction. The chemical combination allows for the investigation of pharmaceutically-privileged regions.

"This is an important first step toward establishing a new technology platform to greatly facilitate drug discovery across a diverse landscape of therapeutic indications," said Micalizio.

A new chemical pathway from simple commercially-available materials to medicinally-relevant molecules. Image courtesy of Glenn Micalizio via Dartmouth.edu

Findings of the study, published in Nature Communications, can provide the basis for a future in large-scale production of new pharmaceuticals.

To test the efficacy of their technique, researchers describe the discovery of a selective toxic molecule to an aggressive and deadly form of a brain tumor known as glioblastoma.

"Glioblastomas are incurable, and existing therapies have horrific side effects," said Arti Gaur, an assistant professor of neurology at Dartmouth's Geisel School of Medicine. "It is extremely exciting and encouraging to see that these novel compounds can selectively kill patient-derived brain tumor cells without harming cells from normal, healthy brain tissue."

The research advances organic chemistry to enable the discovery of new therapeutics for a wide range of malignancies as well as neurodegeneration and neuro-inflammation.

Source: Dartmouth Press Release

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 20, 2020
Drug Discovery & Development
Hyperbaric Oxygen Treatments Reverse Aging
NOV 20, 2020
Hyperbaric Oxygen Treatments Reverse Aging
Researchers from Israel have found that hyperbaric oxygen treatments (HBOT) in healthy aging adults can prevent blood ce ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
NOV 23, 2020
Drug Discovery & Development
Therapeutically Active Ion-Channels
NOV 23, 2020
Therapeutically Active Ion-Channels
Therapeutically relevant ion channels have inspired researchers to look into drugs that can regulate their activity. Ion ...
Loading Comments...